Objective Investigation of the clinical prognostic value of soluble urokinase plasminogen activator receptor (uPAR) forms in blood and tissue extracts from patients with colon and breast cancer, aiming to develop new methods which will aid in the decision-making needed in the management of cancer patients. Fields of science medical and health sciencesclinical medicineoncologybreast cancer Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Topic(s) 1.1.1.-4. - Key action Environment and Health Call for proposal Data not available Funding Scheme RGI - Research grants (individual fellowships) Coordinator COPENHAGEN UNIVERSITY HOSPITAL Address Stransboulevarden 49 2100 Koepenhagen Denmark See on map EU contribution € 0,00
